Want to see GRI full AI Analyst Report?
Total Valuation
GRI Bio has a market cap or net worth of $3.33M. The enterprise value is -$10.78M.
Market Cap$3.33M
Enterprise Value-$10.78M
Share Statistics
GRI Bio has 1,770,838 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,770,838
Owned by Insiders32.35%
Owned by Institutions―
Financial Efficiency
GRI Bio’s return on equity (ROE) is -1.99 and return on invested capital (ROIC) is -197.02%.
Return on Equity (ROE)-1.99
Return on Assets (ROA)-1.38
Return on Invested Capital (ROIC)-197.02%
Return on Capital Employed (ROCE)-1.99
Revenue Per Employee0.00
Profits Per Employee-2.99M
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GRI Bio is ―. GRI Bio’s PEG ratio is 0.00062.
PE Ratio―
PS Ratio0.00
PB Ratio0.11
Price to Fair Value0.11
Price to FCF-0.07
Price to Operating Cash Flow-0.18
PEG Ratio0.00062
Income Statement
In the last 12 months, GRI Bio had revenue of 0.00 and earned -11.96M in profits. Earnings per share was -121.80.
Revenue0.00
Gross Profit-4.00K
Operating Income-11.98M
Pretax Income-11.96M
Net Income-11.96M
EBITDA-11.97M
Earnings Per Share (EPS)-121.80
Cash Flow
In the last 12 months, operating cash flow was -13.87M and capital expenditures -399.00K, giving a free cash flow of -14.27M billion.
Operating Cash Flow-13.87M
Free Cash Flow-14.27M
Free Cash Flow per Share-8.06
Dividends & Yields
GRI Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.46
52-Week Price Change-95.64%
50-Day Moving Average2.17
200-Day Moving Average19.16
Relative Strength Index (RSI)37.41
Average Volume (3m)83.37K
Important Dates
GRI Bio upcoming earnings date is Aug 19, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
GRI Bio as a current ratio of 3.25, with Debt / Equity ratio of 0.55%
Current Ratio3.25
Quick Ratio3.25
Debt to Market Cap0.00
Net Debt to EBITDA0.68
Interest Coverage Ratio0.00
Taxes
In the past 12 months, GRI Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
GRI Bio EV to EBITDA ratio is 0.62, with an EV/FCF ratio of 0.73.
EV to Sales0.00
EV to EBITDA0.62
EV to Free Cash Flow0.73
EV to Operating Cash Flow0.73
Balance Sheet
GRI Bio has $11.05M in cash and marketable securities with $58.00K in debt, giving a net cash position of $10.99M billion.
Cash & Marketable Securities$11.05M
Total Debt$58.00K
Net Cash$10.99M
Net Cash Per Share$6.21
Tangible Book Value Per Share$61.20
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for GRI Bio is $21.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$21.00
Price Target Upside7400.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast97.37%